☐ | Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
Subject Company Information |
Identity and Background of Filing Person |
Past Contacts, Transactions, Negotiations and Agreements |
• | in favor of the adoption of the Merger Agreement and the approval of the Merger and the other transactions contemplated by or in connection with the Merger Agreement and the Support Agreements; |
• | in favor of any other matters necessary or presented or proposed for the transactions to be timely consummated; |
• | in favor of any proposal to adjourn or postpone a meeting of Intevac’s stockholders to a later date if there are not sufficient votes to adopt the Merger Agreement; |
• | against any action, agreement or transaction that would reasonably be expected to (a) result in a breach of any covenant, representation or warranty or any other obligation or agreement of Intevac contained in the Merger Agreement, or of any Supporting Stockholder contained in the Support Agreements, or (b) result in any of the Offer Conditions or conditions to the Merger set forth in the Merger Agreement not being timely satisfied; |
• | against any change in the Intevac Board (unless such proposed change in the Intevac Board was proposed by the Intevac Board and is not in connection with or in support of any actual or potential Acquisition Proposal (as such term is defined in the Merger Agreement)); and |
• | against any Acquisition Proposal and against any other action, agreement or transaction involving Intevac that is intended, or would reasonably be expected, to materially impede, interfere with, delay, postpone, adversely affect or prevent the consummation of the Offer or the Merger or the other transactions contemplated by the Merger Agreement and the Support Agreements. |
Name | Position | ||
Nigel D. Hunton | President and Chief Executive Officer | ||
Cameron McAulay | Chief Financial Officer, Secretary and Treasurer | ||
John Dickinson | Vice President of Operations | ||
Name of Executive Officer or Director | Shares Owned (#) | Total Offer Consideration for Shares ($) | Special Dividend Amount Payable for Shares ($) | ||||||
Executive Officers | |||||||||
Nigel D. Hunton. | 283,122 | 1,132,488 | 14,722 | ||||||
Cameron McAulay | 2,500 | 10,000 | 130 | ||||||
John Dickinson | 49,860 | 199,440 | 2,593 | ||||||
Name of Executive Officer or Director | Shares Owned (#) | Total Offer Consideration for Shares ($) | Special Dividend Amount Payable for Shares ($) | ||||||
Directors | |||||||||
Kevin D. Barber | 56,000 | 224,000 | 2,912 | ||||||
David S. Dury | 212,000 | 848,000 | 11,024 | ||||||
Dorothy D. Hayes | 47,000 | 188,000 | 2,444 | ||||||
Michele F. Klein | 52,000 | 208,000 | 2,704 | ||||||
Eiji Miyanaga | — | — | — | ||||||
Ryan L. Vardeman | 1,053,924(1) | 4,215,696 | 54,804 | ||||||
(1) | Represents Shares held by Palogic Value Fund, L.P. (Palogic Value Fund). Palogic Value Management, L.P. (Palogic Value Management), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC (Palogic Capital Management), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. |
• | each Company Option with an exercise price per Share that is less than the Offer Consideration (each, an “In-the-Money Option”) that is then outstanding and unvested as of immediately prior to the Effective Time will vest in full and be cancelled in exchange for (A) an amount in cash equal to the product of (x) the total number of Shares subject to such In-the-Money Option immediately prior to the Effective Time multiplied by (y) the excess of the amount of the Offer Consideration over the applicable exercise price per Share of such In-the-Money Option; and |
• | each Company Option other than an In-the-Money Option that is then outstanding and unexercised, whether or not vested, will be cancelled with no consideration payable in respect thereof. |
Name of Executive Officer or Director | Number of Shares Underlying In-the -Money Options (#) | Offer Consideration for In-the-Money Options ($) | ||||
Executive Officers | ||||||
Nigel D. Hunton | — | — | ||||
Cameron McAulay | — | — | ||||
John Dickinson | — | — | ||||
Directors | ||||||
Kevin D. Barber | — | — | ||||
David S. Dury | — | — | ||||
Dorothy D. Hayes | — | — | ||||
Michele F. Klein | — | — | ||||
Eiji Miyanaga | 10,300 | 4,738 | ||||
Ryan L. Vardeman | 10,300 | 14,935 | ||||
Name of Executive Officer or Director | Number of Company RSUs (#) | Total Offer Consideration for Company RSUs ($) | ||||
Executive Officers | ||||||
Nigel D. Hunton | 277,985 | 1,111,940 | ||||
Cameron McAulay | 138,000 | 552,000 | ||||
John Dickinson | 113,581 | 454,324 | ||||
Directors | ||||||
Kevin D. Barber | 12,000 | 48,000 | ||||
David S. Dury | 12,000 | 48,000 | ||||
Dorothy D. Hayes | 12,000 | 48,000 | ||||
Michele F. Klein | 12,000 | 48,000 | ||||
Eiji Miyanaga | 12,000 | 48,000 | ||||
Ryan L. Vardeman | 12,000 | 48,000 | ||||
• | Immediately prior to the Effective Time, each Company PRSU granted during calendar year 2022 that is then outstanding will be cancelled and the holder thereof will be entitled to an amount in cash equal to the product of (x) 25 percent of the “Number of RSUs Subject to Award” listed in the applicable award agreement (such number of Company PRSUs, the “Cashed-Out 2022 Company PRSUs”) multiplied by (y) the Offer Consideration; |
• | Immediately prior to the Effective Time, each Company PRSU granted during calendar year 2025 that is then outstanding will be cancelled and the holder thereof will be entitled to an amount in cash equal to the product of (x) the “Target RSUs” listed in the applicable award agreement (such number of Company PRSUs, the “Cashed-Out 2025 Company PRSUs”) multiplied by (y) the Offer Consideration; and |
• | Prior to the Effective Time, each Company PRSU granted during calendar year 2023 and each Company PRSU granted during calendar year 2024 that is outstanding and unvested will be cancelled with no consideration payable in respect thereof. |
Name of Executive Officer or Director | Cashed-Out 2022 Company PRSUs (#) | Cashed-Out 2025 Company PRSUs (#) | Total Offer Consideration for Company PRSUs ($) | ||||||
Executive Officers | |||||||||
Nigel D. Hunton | 166,750 | 240,000 | 1,627,000 | ||||||
Cameron McAulay | — | 135,000 | 540,000 | ||||||
John Dickinson | 20,650 | 75,000 | 382,600 | ||||||
Directors | |||||||||
Kevin D. Barber | — | — | — | ||||||
David S. Dury | — | — | — | ||||||
Dorothy D. Hayes | — | — | — | ||||||
Michele F. Klein | — | — | — | ||||||
Eiji Miyanaga | — | — | — | ||||||
Ryan L. Vardeman | — | — | — | ||||||
• | continuing payments of Mr. Hunton’s base salary in effect on the date of Mr. Hunton’s termination, payable in accordance with Intevac’s standard payroll procedures for a period of 12 months (or, if such termination occurs within the 12-month period following a “change in control” (as defined in Intevac’s 2020 Equity Incentive Plan and which includes the Merger) (the “Change in Control Period”), for a period of 18 months) (the “Severance Period”); |
• | the immediate vesting of each of Mr. Hunton’s then-outstanding equity awards as to 50 percent of the unvested number of Shares subject to each equity award (or, if such termination occurs within the Change in Control Period, the immediate vesting as of 100 percent of Mr. Hunton’s then-outstanding equity awards), in each case other than performance-based equity awards, which will instead be treated as provided in the award agreement related to such Intevac equity; |
• | payment or reimbursement for premiums for medical, vision and dental coverage under COBRA for Mr. Hunton and his eligible dependents for up to the length of the Severance Period; |
• | a lump sum payment equal to a prorated portion of the average bonus paid to Mr. Hunton over the three most recently completed bonus periods or such lesser period of time that Mr. Hunton has been employed (or at target bonus if no bonus period has been completed), or, if the termination occurs within the Change in Control Period, payment of 150 percent of Mr. Hunton’s target bonus; |
• | if bonuses have not been paid for the calendar year preceding the year in which the termination occurs, a lump sum payment equal to the bonus that Mr. Hunton would have received had he remained employed through the bonus payment date based on actual performance; and |
• | if Mr. Hunton’s termination occurs within the Change in Control Period, a lump sum payment equal to a prorated portion of Mr. Hunton’s target bonus, based on the number of completed days in such year for which Mr. Hunton was employed by Intevac as of the termination date. |
• | continuing payments of the executive officer’s base salary in effect on the date of the executive officer’s termination, payable in accordance with Intevac’s standard payroll procedures for a period of 12 months; |
• | immediate vesting of each of the executive officer’s then-outstanding Intevac equity awards other than performance-based equity awards, which will instead be treated as provided in the award agreement related to such Intevac equity; |
• | payment or reimbursement for premiums for medical, vision and dental coverage under COBRA for the executive officer and the executive officer’s eligible dependents for up to 12 months; |
• | a lump sum payment equal to 100 percent of the executive officer’s target bonus; |
• | if bonuses have not been paid for the calendar year preceding the year in which the termination occurs, a lump sum payment equal to the bonus that the executive officer would have received had the executive officer remained employed through the bonus payment date based on actual performance; and |
• | a lump sum payment equal to a prorated portion of the executive officer’s target bonus, based on the number of completed days in such year for which the executive officer was employed by Intevac as of the termination date. |
• | that the Effective Time will occur on February 27, 2025 (which is the assumed closing date of the Merger solely for purposes of this Schedule 14D-9, including this golden parachute compensation disclosure); |
• | that the named executive officer will have a qualifying termination of his employment at the Effective Time that results in severance benefits becoming payable to him under his Employment Agreement or CIC Agreement (as applicable); and |
• | that no payment is reduced pursuant to the terms of the Employment Agreement and CIC Agreements described above as a result of Sections 280G and 4999 of the U.S. Internal Revenue Code. |
Name | Cash ($)(1) | Equity ($)(2) | Perquisites/ Benefits ($)(3) | Total ($)(4) | ||||||||
Nigel D. Hunton | 1,902,174 | 2,738,940 | 82,890 | 4,724,004 | ||||||||
Cameron McAulay | 646,104 | 1,092,000 | — | 1,738,104 | ||||||||
John Dickinson | 620,600 | 836,924 | 46,272 | 1,503,796 | ||||||||
(1) | The amount for each named executive officer represents the “double-trigger” cash severance payments to which the named executive officer may become entitled under his Employment Agreement or CIC Agreement (as applicable) in connection with a qualifying termination on or within twelve months after a change in control, as described in further detail in the section of this Schedule 14D-9 captioned “—Arrangements Between Intevac and its Executive Officers, Directors and Affiliates—Potential Payments to Intevac’s Executive Officers in Connection with a Change in Control Termination.” The amount listed for Mr. Hunton represents (a) continuing payments of his base salary in effect on the date of his termination, payable in accordance with Intevac’s standard payroll procedures for a period of 18 months, (b) a lump sum payment equal to 150 percent of his target bonus, and (c) a lump sum payment equal to a prorated portion of his target bonus, based on the number of completed days in such year for which he was employed by Intevac as of the termination date. In the cases of Messrs. McAulay and Dickinson, the amount listed for each such named executive officer represents (a) severance from Intevac in the amount of 12 months of the named executive officer’s then-existing base salary, (b) a lump sum payment equal to 100 percent of the named executive officer’s target bonus, and (c) a lump sum payment equal to a prorated portion of the executive officer’s target bonus, based on the number of completed days in such year for which the executive officer was employed by Intevac as of the termination date. The following table sets forth the value of each of the base salary and bonus severance payable to a named executive officer under the terms of his Employment Agreement or CIC Agreement. |
Name | Base Salary Severance ($) | Target Bonus Severance ($) | Prorated Target Bonus Severance ($) | ||||||
Nigel D. Hunton | 900,900 | 900,900 | 100,374 | ||||||
Cameron McAulay | 380,000 | 228,000 | 38,104 | ||||||
John Dickinson | 365,000 | 219,000 | 36,600 | ||||||
(2) | The amount for each named executive officer amount represents “single trigger” vesting acceleration of 100 percent of (i) the unvested portion of his In-the-Money Options, (ii) his Company RSUs, and (iii) certain of his Company PRSUs, in each case pursuant to the Merger Agreement, as described in further detail in the section of this Schedule 14D-9 captioned “—Arrangements Between Intevac and its Executive Officers, Directors and Affiliates—Treatment of Company Equity Awards in the Transactions.” These amounts assume that no equitable adjustments are made to such equity awards in order to account for the payment of the Special Dividend. |
Name | Company Options ($) | Company RSUs ($) | Company PRSUs ($) | Total ($) | ||||||||
Nigel D. Hunton | — | 1,111,940 | 1,627,000 | 2,738,940 | ||||||||
Cameron McAulay | — | 552,000 | 540,000 | 1,092,000 | ||||||||
John Dickinson | — | 454,324 | 382,600 | 836,924 | ||||||||
(3) | The amount for each named executive officer represents payment or reimbursement for premiums for medical, vision and dental coverage under COBRA for the named executive officer and his eligible dependents for 12 months (or in Mr. Hunton’s case, 18 months). These amounts are a “double-trigger” severance benefit that each such named executive officer may become entitled to receive under his CIC Agreement in connection with a qualifying termination within 12 months following a “change in control,” as described in further detail in the section of this Schedule 14D-9 captioned “—Arrangements Between Intevac and its Executive Officers, Directors and Affiliates—Potential Payments to Intevac’s Executive Officers in Connection with a Change in Control Termination—Amended and Restated Change in Control Agreements with Cameron McAulay and John Dickinson.” |
(4) | Under each of the Employment Agreement and the CIC Agreements, amounts are subject to reduction in the event the applicable named executive officer would receive a greater benefit on an after-tax basis by having some of his change in control-related payments and benefits being cut back rather than paying the excise tax under Section 4999 of the Code on such amounts. These amounts assume no such reduction is applied. |
Annual Cash Compensation ($) | |||
Non-Chair Board Retainer | 45,000 | ||
Additional Board Chair Retainer | 28,000 | ||
Audit Committee Chairmanship Compensation | 15,000 | ||
Human Capital Committee Chairmanship Compensation | 10,000 | ||
Nominating and Governance Committee Chairmanship Compensation | 8,000 | ||
Audit Committee Member Compensation | 8,500 | ||
Human Capital Committee Chairmanship Compensation | 5,000 | ||
Nominating and Governance Committee Member Compensation | 4,000 | ||
• | for any breach of the director’s duty of loyalty to Intevac or its stockholders; |
• | for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law; |
• | for unlawful payments of dividends or unlawful stock repurchases or redemptions, as provided under Section 174 of the DGCL; or |
• | for any transaction from which the director derived an improper personal benefit. |
The Solicitation or Recommendation |
• | Attractive Price. The Intevac Board concluded that the Offer Consideration represented an attractive valuation for Intevac. As part of this, the Intevac Board considered how the Offer Consideration of $4.00 per Share, without interest and subject to reduction for any applicable withholding of taxes, plus the Quarterly Dividend of $0.05 per Share and the Special Dividend of $0.052 per Share, aggregated to $4.102 per Share. The Intevac Board believed that the Aggregate Cash Value represented a significant and certain premium over the market price of the Shares. When evaluating the Aggregate Cash Value, the Intevac Board considered the following factors, among others: |
○ | The fact that the Offer Consideration, without interest and subject to reduction for any applicable withholding of taxes, plus the Quarterly Dividend and the Special Dividend, represents (i) a premium of 45 percent to Intevac’s closing price of $2.83 per share on December 11, 2024, which was the closing price on the day prior to Intevac’s announcement that it had renewed its focus on pursuing strategic options; (ii) a premium of approximately 21 percent to Intevac’s closing price of $3.38 per share on February 12, 2025, which was the closing price on the day prior to the announcement of the Transactions; and (iii) an aggregate value of approximately $119,000,000 including both dividends. |
○ | The belief of the Intevac Board that it was unlikely to find an alternative transaction at a per Share value higher than that contemplated by the Transactions in light of (i) the repeated public disclosures that Intevac was pursuing strategic alternatives, (ii) the efforts undertaken by the Strategic Committee, with the assistance of Houlihan Lokey, to identify third parties who might have an interest in pursuing a transaction with Intevac, (iii) the fact that, during 2023 and 2024, at the direction of Intevac, Houlihan Lokey contacted over 60 third parties concerning their potential interest in a transaction with Intevac, (iv) the fact that only Seagate had engaged with Intevac in substantive work toward a transaction or made a proposal to engage in a transaction, (v) the fact that additional efforts to solicit a transaction were unlikely to yield an acquisition of Intevac on terms competitive with Seagate’s offer and on the timing of the Transactions and (vi) the fact that Intevac actively solicited increases in the offer made by Seagate and Seagate indicated that it was not willing to further increase the value of its offer. |
○ | The Intevac Board’s familiarity with the business, operations, prospects, strategic positioning (including the results of efforts to diversify Intevac's business), short- and long-term operating plans, assets, liabilities and financial condition of Intevac, and its determination that the certainty of value and liquidity of the Offer Consideration, without interest and subject to reduction for any applicable withholding of taxes, plus the Quarterly Dividend and the Special Dividend, is more favorable to Intevac’s stockholders than the potential value that could reasonably be expected to be generated from the alternative of Intevac continuing to operate independently and pursuing its current business and financial plans on a stand-alone basis, taking into account the execution risks associated with continued independence, including the risks set forth under the caption “Risk Factors” in Intevac’s Form 10-K for the period ended December 28, 2024. |
• | Other Strategic Alternatives. The Intevac Board’s belief, after a thorough review of other strategic alternatives (including continuing to operate on a stand-alone basis or making a strategic acquisition), in each case taking into account the potential benefits, risks and uncertainties associated with those alternatives, that the Offer and the Merger represent Intevac’s best reasonably available prospect for maximizing stockholder value. |
• | Customer Dynamics and Seagate Relationship. The Intevac Board’s consideration of the limited number of customers for Intevac’s products and Intevac’s existing and significant commercial relationship with, and reliance on, Seagate for current and future sales. Seagate has been a long-time customer of Intevac and accounted for over 90 percent of Intevac’s consolidated net revenues in each of fiscal year 2024 and 2023. In addition, the Intevac Board considered that Seagate is not contractually required to continue to do business with Intevac in the long-term, and the limited number |
• | Potentially Limited Period of Opportunity. The Intevac Board’s belief that prolonging the strategic review process could have resulted in the loss of an opportunity to consummate a transaction with Seagate on the terms of the Offer, including the aggregate value represented by the Offer Consideration, without interest and subject to reduction for any applicable withholding of taxes, plus the Quarterly Dividend and the Special Dividend, and could have distracted Intevac management from implementing Intevac’s business plan. |
• | Speed of Consummation. The fact that the Transactions were anticipated to be structured as a two-step transaction under Section 251(h) of the DGCL, resulting in a higher likelihood of Intevac’s stockholders receiving the Offer Consideration pursuant to the Offer, in addition to the Quarterly Dividend and the Special Dividend, in a relatively short time frame, followed promptly by the Merger in which Intevac’s stockholders who do not tender in the Offer will receive the same consideration per share as is paid in the Offer, in addition to the Quarterly Dividend and the Special Dividend, and that such relatively short timeframe would be expected to reduce the uncertainty and potential disruption to Intevac’s business pending the closing of the Merger, as well as the fact that under the terms of the Merger Agreement, Seagate, under certain circumstances, has the right to elect to pursue completion of the Transactions through a long-form merger subject to a stockholder vote rather than through a tender offer followed by a back-end, short-form merger. |
• | High Likelihood of Closing. The Intevac Board’s belief that the likelihood of completing the Transactions is high, particularly in light of the terms of the Merger Agreement, including (i) the conditions to the Offer and the Merger being specific and limited, (ii) the possibility that the Transactions could be completed without significant regulatory filings or investigations; (iii) the exceptions contained within the “material adverse effect” definition, which generally defines the standard for closing risk; and (iv) the size and financial strength of Seagate, and Seagate’s ability to fund the Offer Consideration with cash. |
• | No Financing Condition. The fact that the Transactions are not subject to a financing condition. |
• | Houlihan Lokey Analysis and Fairness Opinion. The opinion of Houlihan Lokey rendered to the Intevac Board, at the request of the Intevac Board, on February 12, 2025, which was subsequently confirmed by delivery of a written opinion dated February 12, 2025 that, as of such date and based upon and subject to the assumptions made, procedures followed, matters considered, and qualifications and limitations upon the review undertaken by Houlihan Lokey in preparing its opinion, the Offer Consideration, without interest and subject to reduction for any applicable withholding of taxes, plus the Quarterly Dividend and the Special Dividend, to be paid to the holders of Shares (other than Seagate, Purchaser or their respective affiliates, to the extent that they own any Shares) pursuant to the Merger Agreement was fair to such holders from a financial point of view, as more fully described below under the caption “Opinion of Houlihan Lokey Capital, Inc.” |
• | Successful Negotiations with Seagate. The terms of the Merger Agreement, which were the product of arms’-length negotiations, and the Intevac Board’s belief that the Merger Agreement contained terms that provided the Intevac Board with a high level of closing certainty. The factors considered include: |
○ | Intevac’s ability, under certain circumstances, to furnish information to, and conduct negotiations with, third parties regarding acquisition proposals. |
○ | The Intevac Board’s view that the terms of the Merger Agreement would be unlikely to deter third parties from making a superior proposal. |
○ | The Intevac Board’s ability, under certain circumstances, to withdraw or modify its recommendation that Intevac stockholders tender their Shares pursuant to the Offer. |
○ | The Intevac Board’s ability, under certain circumstances, to terminate the Merger Agreement to enter into an alternative acquisition agreement. In that regard, the Intevac Board believed that the termination fee of $4,300,000 payable by Intevac in such instance was reasonable, consistent with or below similar fees payable in comparable transactions, and not preclusive of other offers. |
○ | The limited conditions to Seagate’s and Purchaser’s obligations to consummate the Transactions, making the Transactions reasonably likely to be consummated. |
○ | The consummation of the Transactions not being subject to a financing condition. |
○ | Intevac’s ability, under certain circumstances and upon written request to Purchaser, to extend the Offer beyond the initial expiration date of the Offer or, if applicable, subsequent expiration dates. |
• | Opportunity to Accept a Superior Proposal. The fact that the terms of the Merger Agreement permit Intevac to respond to unsolicited proposals in certain circumstances, and that the Merger Agreement permits the Intevac Board in certain circumstances to terminate the Merger Agreement in order to enter into a definitive agreement with respect to an unsolicited superior proposal, subject to the payment of a termination fee of $4,300,000, which amount the Intevac Board believed to be reasonable under the circumstances and unlikely to serve as a meaningful deterrent to other acquisition proposals. |
• | Offer Acceptance by Stockholders. The fact that closing of the Offer would be subject to tenders of Shares by holders that would constitute a majority of the Shares. |
• | Tender and Support Agreements. The fact that the Supporting Stockholders, who collectively held approximately 23.5 percent of the outstanding Shares as of February 11, 2025, had entered into Tender and Support Agreements with Seagate and Purchaser and agreed to support the Transactions and tender their Shares in the Offer. |
• | Appraisal Rights. That stockholders who do not believe that the Offer Consideration represents fair consideration for their Shares will have an opportunity to pursue appraisal rights under Section 262 of the DGCL. |
• | Opportunity Costs. The fact that Intevac will no longer exist as an independent public company, and Intevac’s stockholders will forgo any potential increase in its value above the amount of the Offer Consideration, without interest and subject to reduction for any applicable withholding of taxes, plus the Quarterly Dividend and the Special Dividend, that might result from Intevac’s possible growth. |
• | Potential Negative Impact on Intevac’s Business. The possible negative effect of the Offer and the Merger and public announcement of the Offer and the Merger on Intevac’s operations and Intevac’s relationships with suppliers, business partners, management and employees. |
• | Prohibition Against Solicitations. The fact that the Merger Agreement precludes Intevac from soliciting competing acquisition proposals and obligates Intevac to pay Seagate a termination fee equal to $4,300,000 under specified circumstances, which could discourage the making of a competing acquisition proposal or adversely impact the price offered in such a proposal. |
• | Business Operation Restrictions. The fact that the Merger Agreement imposes customary restrictions on the conduct of Intevac’s business in the pre-closing period, which may adversely affect Intevac by delaying or preventing Intevac from pursuing non-ordinary course opportunities that may arise. |
• | Closing Conditions. The fact that the completion of the Offer and the Merger requires the satisfaction of closing conditions that are not fully within Intevac’s control. |
• | Effect of Failure to Consummate Transactions. The possibility that the Transactions might not be consummated, and if they are not consummated, that: (1) Intevac’s directors, management and other employees will have expended extensive time and effort and will have experienced significant distractions from their work during the pendency of the Transactions; (2) Intevac will have incurred significant transaction and other costs; (3) Intevac’s continuing business relationships with customers, business partners and employees may be adversely affected; (4) the trading price of the Shares could be adversely affected; (5) the other contractual and legal remedies available to Intevac in the event of |
• | Taxable Consideration. The expectation that the receipt of the Offer Consideration in exchange for Shares pursuant to the Offer or the Merger, as applicable, and of the receipt of the Quarterly Dividend and the Special Dividend, will each generally be a taxable transaction for U.S. federal income tax purposes. |
• | Litigation Risk. The inherent risk of litigation in relation to the sale of Intevac, including potential stockholder litigation in connection with the execution of the Merger Agreement and the consummation of the Offer and the Merger. |
• | Transaction Expenses. The substantial transaction expenses to be incurred in connection with the Transactions and the negative impact of such expenses on Intevac’s cash reserves and operating results should the Offer and the Merger not be completed. |
Fiscal year ended December 31, | |||||||||
(Dollars in millions) | 2025E | 2026E | 2027E | ||||||
Total Revenue | $54.6 | $64.6 | $70.6 | ||||||
Direct Cost of Sales | $(27.7) | $(32.2) | $(36.1) | ||||||
Direct Margin | $26.8 | $32.3 | $34.5 | ||||||
Other Cost of Sales | $(3.9) | $(1.5) | $(1.6) | ||||||
Total Cost of Sales | $(31.7) | $(33.7) | $(37.7) | ||||||
Research and Development | $(7.4) | $(7.6) | $(7.8) | ||||||
Management, General and Administrative | $(14.9) | $(15.0) | $(15.4) | ||||||
Depreciation and Amortization | $0.8 | $1.0 | $1.0 | ||||||
EBITDA(1) | $1.4 | $9.3 | $10.7 | ||||||
Depreciation and Amortization | $(0.8) | $(1.0) | $(1.0) | ||||||
EBIT(2) | $0.6 | $8.3 | $9.7 | ||||||
Taxes(3) | $(0.8) | $(0.8) | $(2.5) | ||||||
Unlevered Earnings(4) | $(0.2) | $7.5 | $7.3 | ||||||
Depreciation and Amortization | $0.8 | $1.0 | $1.0 | ||||||
Capital Expenditures | $(1.5) | $(1.0) | $— | ||||||
Change in Net Working Capital | $(2.8) | $(1.6) | $2.0 | ||||||
Cash Flow Adjustment(5) | $0.8 | $(1.3) | $(1.3) | ||||||
Unlevered Free Cash Flow(6) | $(2.8) | $4.6 | $9.0 | ||||||
(1) | EBITDA is defined as Intevac’s earnings before interest, taxes, depreciation and amortization of intangible assets. |
(2) | EBIT is defined as earnings before interest expenses and taxes. |
(3) | Cash taxes include (i) $0.8 million in royalty tax payments for 2025E–2027E, and (ii) a 17% tax rate starting in 2027E. |
(4) | Unlevered earnings is defined as Intevac’s EBIT less taxes. |
(5) | Represents cash adjustment for (i) amount of rent paid in excess of amount expensed, (ii) employee retention credit, and (iii) residual severance payments. |
(6) | Unlevered free cash flow is defined as Intevac’s EBITDA less taxes, capital expenditures, plus or minus changes in net working capital and plus or minus a cash flow adjustment. |
Fiscal year ended December 31, | |||||||||||||||
(Dollars in millions) | 2025E | 2026E | 2027E | 2028E | 2029E | ||||||||||
Total Revenue | $56.6 | $72.7 | $80.5 | $81.3 | $92.5 | ||||||||||
Direct COGS | $29.4 | $36.3 | $41.2 | $41.6 | $47.6 | ||||||||||
Other Cost of Sales | $3.9 | $1.5 | $1.6 | $1.6 | $1.9 | ||||||||||
Total Cost of Revenues | $33.4 | $37.7 | $42.8 | $43.2 | $49.5 | ||||||||||
Gross Profit | $23.2 | $35.0 | $37.7 | $38.1 | $43.0 | ||||||||||
Management, General and Administrative | $14.9 | $15.0 | $15.4 | $15.7 | $16.1 | ||||||||||
R&D | $7.4 | $7.6 | $7.8 | $8.1 | $8.3 | ||||||||||
Total Opex | $22.3 | $22.6 | $23.2 | $23.8 | $24.4 | ||||||||||
EBIT | $1.0 | $12.4 | $14.6 | $14.3 | $18.6 | ||||||||||
Total Other Income, Interest and Taxes (Loss) | $0.1 | $(0.5) | $(0.5) | $(0.1) | $(0.1) | ||||||||||
Net Income | $1.1 | $11.9 | $14.1 | $14.2 | $18.4 | ||||||||||
Total Non-GAAP Adjustments | $— | $— | $— | $— | $— | ||||||||||
Total Management Adjustments to EBITDA | $12.2 | $10.4 | $10.8 | $10.8 | $11.1 | ||||||||||
Adjusted EBITDA | $13.3 | $22.3 | $24.9 | $24.9 | $29.5 | ||||||||||
Fiscal year ended December 31, | |||||||||
(Dollars in millions) | 2025E | 2026E | 2027E | ||||||
Total revenue | $54.6 | $64.6 | $25.0 | ||||||
Direct Cost of Sales | $22.9 | $30.9 | $7.1 | ||||||
Opex | $22.3 | $22.6 | $19.3 | ||||||
EBIT | $0.6 | $8.3 | $(12.2) | ||||||
EBITDA | $1.4 | $9.3 | $(11.1) | ||||||
Net Income | $1.7 | $8.9 | $(11.6) | ||||||
Depreciation and Amortization | $0.8 | $1.0 | $1.0 | ||||||
Equity-based compensation | $3.0 | $3.1 | $3.1 | ||||||
Deferred income taxes | $0.8 | $1.1 | $1.2 | ||||||
Change in Net Working Capital | $(2.8) | $(1.6) | $7.0 | ||||||
Cash Used in Investing Activities | $(1.5) | $(1.0) | $— | ||||||
Rental – Cash Payment above impairment | $(1.3) | $(1.3) | $(1.3) | ||||||
ERC | $2.4 | $— | $— | ||||||
Residual Severance payments | $(0.3) | $— | $— | ||||||
Total Cash Generation | $2.8 | $10.1 | $(0.6) | ||||||
1. | reviewed a draft dated February 10, 2025 of the Merger Agreement; |
2. | reviewed certain publicly available business and financial information relating to Intevac that Houlihan Lokey deemed to be relevant; |
3. | reviewed certain information relating to the historical, current and future operations, financial condition and prospects of Intevac made available to Houlihan Lokey by Intevac, including the Base Case; for further information regarding the Base Case and the other Forecasts, see the section of this Schedule 14D-9 captioned “—Certain Company Management Forecasts”); |
4. | spoke with certain members of the management of Intevac and certain of its representatives and advisors regarding the business, operations, financial condition and prospects of Intevac, the Transactions and related matters; |
5. | compared the financial and operating performance of Intevac with that of other public companies that Houlihan Lokey deemed to be relevant; |
6. | reviewed the current and historical market prices and trading volume for certain of Intevac’s publicly traded securities, and the current and historical market prices and trading volume of the publicly traded securities of certain other companies that Houlihan Lokey deemed to be relevant; and |
7. | conducted such other financial studies, analyses and inquiries and considered such other information and factors as Houlihan Lokey deemed appropriate. |
• | Enterprise Value — generally, the value as of a specified date of the relevant company’s outstanding equity securities (taking into account outstanding options and other securities convertible, exercisable or exchangeable into or for equity securities of the company) plus the amount of its net debt (the amount of its outstanding indebtedness, non-convertible preferred stock, capital lease obligations and non-controlling interests less the amount of cash and cash equivalents on its balance sheet). |
• | EBITDA — generally, the amount of the relevant company’s earnings before interest, taxes, depreciation and amortization for a specified time period. |
• | Adjusted EBITDA — generally, the amount of the relevant company’s earnings before interest, taxes, depreciation and amortization for a specified time period, adjusted for certain non-recurring items. |
• | Enterprise value as a multiple of estimated 2025 Adjusted EBITDA; |
• | Enterprise value as a multiple of estimated 2026 Adjusted EBITDA; and |
• | Enterprise value as a multiple of estimated 2027 Adjusted EBITDA. |
• | Advanced Process Systems Corporation |
• | Aixtron SE |
• | ASMPT Limited |
• | Avaco Co., Ltd. |
• | Ichor Holdings, Ltd. |
• | JEOL Ltd. |
• | Jusung Engineering Co., Ltd. |
• | Kokusai Electric Corporation |
• | Mycronic AB (publ) |
• | Nanofilm Technologies International Limited |
• | Optorun Co., Ltd. |
• | Oxford Instruments plc |
• | Samco Inc. |
• | Shibaura Mechatronics Corporation |
• | ULVAC, Inc. |
• | UVAT Technology Co., Ltd. |
• | Veeco Instruments Inc. |
• | Wonik IPS Co., Ltd. |
Enterprise Value to Adjusted EBITDA | ||||||||||||
CY 2025E | CY 2026E | CY 2027E | Average of CY25E-CY27E | |||||||||
Low | 2.3x | 2.1x | 4.7x | 2.2x | ||||||||
25th Percentile | 5.6x | 4.9x | 7.1x | 5.2x | ||||||||
Median | 8.1x | 7.1x | 7.5x | 7.3x | ||||||||
Mean | 8.8x | 7.7x | 10.6x | 8.1x | ||||||||
75th Percentile | 10.7x | 9.7x | 14.0x | 9.7x | ||||||||
High | 18.5x | 19.3x | 20.1x | 19.1x | ||||||||
Persons/Assets Retained, Employed, Compensated or Used |
Interest in Securities of the Subject Company |
Purpose of the Transaction and Plans or Proposals |
• | a tender offer or other acquisition of Intevac’s securities by Intevac or any other person; |
• | any extraordinary transaction, such as a merger, reorganization or liquidation, involving Intevac; |
• | any purchase, sale or transfer of a material amount of assets of Intevac; or |
• | any material change in the present dividend rate or policy, or indebtedness or capitalization of Intevac. |
Additional Information |
• | the transaction in which the stockholder became an interested stockholder or the business combination was approved by the board of directors of the corporation before the other party to the business combination became an interested stockholder; |
• | upon completion of the transaction that made it an interested stockholder, the interested stockholder owned at least 85 percent of the voting stock of the corporation outstanding at the commencement of the transaction (excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) the voting stock owned by directors who are also officers or held in employee benefit plans in which the employees do not have a confidential right to tender stock held by the plan); or |
• | the business combination was approved by the board of directors of the corporation and authorized at a meeting of stockholders by the affirmative vote of the holders of at least 66 2/3 percent of the outstanding voting stock which the interested stockholder did not own. |
• | the person must, within the later of the Consummation of the Offer and twenty (20) days after the mailing of this Schedule 14D-9, deliver to Intevac a written demand for appraisal of their Shares, which demand must reasonably inform Intevac of the identity of the stockholder or the beneficial owner, as applicable, and that the stockholder or beneficial owner, as applicable, intends thereby to demand appraisal of such Shares (and, in the case of a demand made by a beneficial owner, the demand must reasonably identify the holder of record of the Shares for which the demand is made, be accompanied by documentary evidence of the beneficial owner’s beneficial ownership of the Shares for which appraisal is demanded, include a statement that such documentary evidence is a true and correct copy of what it purports to be and provide an address at which the beneficial owner consents to receive notices given by the Surviving Corporation in the Merger under Section 262 and to be set forth on the verified list required by subsection (f) of Section 262); |
• | the person must not tender his, her or its Shares pursuant to the Offer; |
• | the person must continuously hold or beneficially own, as applicable, the Shares from the date of making the demand through the Effective Time (if a stockholder who demanded appraisal transfers or a beneficial owner who demanded appraisal ceases to beneficially own the Shares before the Effective Time, such person will lose appraisal rights with respect to the Shares); and |
• | otherwise comply with Section 262. |
Exhibits |
Exhibit No. | Description | ||
Offer to Purchase dated March 3, 2025 (incorporated by reference to Exhibit (a)(1)(A) to the Schedule TO). | |||
Letter of Transmittal (incorporated by reference to Exhibit (a)(1)(B) to the Schedule TO). | |||
Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees (incorporated by reference to Exhibit (a)(1)(C) to the Schedule TO). | |||
Letter to Clients for Use by Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees (incorporated by reference to Exhibit (a)(1)(D) to the Schedule TO). | |||
Summary Advertisement as published in The New York Times on March 3, 2025 (incorporated by reference to Exhibit (a)(1)(E) to the Schedule TO). | |||
A joint Press Release, dated February 13, 2025, issued by Intevac, Inc. and Seagate Technology Holdings plc (incorporated by reference to Exhibit 99.2 to the Current Report on Form 8-K, File No. 000-26946, filed by Intevac, Inc. on February 13, 2025). | |||
Email from Nigel Hunton, President and Chief Executive Officer of Intevac, sent to Intevac’s employees, dated February 13, 2025 (incorporated by reference to Exhibit 99.2 to the Schedule 14D-9C filed by Intevac, Inc. on February 13, 2025). | |||
Frequently Asked Questions, sent to Intevac’s employees, dated February 13, 2025 (incorporated by reference to Exhibit 99.3 to the Schedule 14D-9C filed by Intevac, Inc. on February 13, 2025). | |||
Frequently Asked Questions, sent to Intevac’s employees, dated February 27, 2025 (incorporated by reference to Exhibit 99.1 to the Schedule 14D-9C filed by Intevac, Inc. on February 28, 2025). | |||
Opinion of Houlihan Lokey Capital, Inc., dated February 12, 2025 (included as Annex A of this Schedule 14D-9). | |||
Agreement and Plan of Merger, dated as of February 13, 2025, by and among Seagate Technology Holdings plc, Intevac, Inc., and Irvine Acquisition Holdings, Inc., (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K, File No. 000-26946, filed by Intevac, Inc. on February 13, 2025). | |||
Non-Binding Term Sheet, dated as of January 29, 2025, by and between Seagate Technology Holdings plc and Intevac, Inc. (incorporated by reference to Exhibit (d)(3) to the Schedule TO). | |||
Letter agreement, dated as of January 3, 2025, between Intevac, Inc. and Seagate Technology Holdings plc (incorporated by reference to Exhibit (d)(4) to the Schedule TO). | |||
Form of Tender and Support Agreement, dated as of February 13, 2025, by and among Seagate Technology Holdings plc, Irvine Acquisition Holdings, Inc. and certain stockholders of Intevac, Inc. (incorporated by reference to Exhibit 99.1 to the Current Report on Form 8-K, File No. 000-26946, filed by Intevac, Inc. on February 13, 2025). | |||
Certificate of Incorporation of Intevac, Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, File No. 000-26946, filed by Intevac, Inc. on July 23, 2007). | |||
Amended and Restated Bylaws of Intevac, Inc., dated as of February 13, 2025 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, File No. 000-26946, filed by Intevac, Inc. on February 13, 2025). | |||
Intevac, Inc. 2003 Employee Stock Purchase Plan, as amended February 15, 2024 (incorporated by reference to Appendix A to Definitive Proxy Statement, File No. 000-26946, filed by Intevac, Inc. on April 11, 2018). | |||
Intevac, Inc. 2012 Equity Incentive Plan, as amended March 21, 2018 (incorporated by reference to Appendix B to Definitive Proxy Statement, File No. 000-26946, filed by Intevac, Inc. on April 11, 2018). | |||
Form of Restricted Stock Unit Agreement for 2012 Equity Incentive Plan (incorporated by reference to Exhibit 10.4 to Quarterly Report on Form 10-Q, File No. 000-26946, filed by Intevac, Inc. on May 1, 2012). | |||
Exhibit No. | Description | ||
Form of Restricted Stock Agreement for 2012 Equity Incentive Plan (incorporated by reference to Exhibit 10.5 to Quarterly Report on Form 10-Q, File No. 000-26946, filed by Intevac, Inc. on May 1, 2012). | |||
Form of Stock Option Agreement for 2012 Equity Incentive Plan (incorporated by reference to Exhibit 10.6 to Quarterly Report on Form 10-Q, File No. 000-26946, filed by Intevac, Inc. on May 1, 2012). | |||
Intevac, Inc. 2020 Equity Incentive Plan, as amended February 15, 2024 (incorporated by reference to Appendix B to Definitive Proxy Statement, File No. 000-26946, filed by Intevac, Inc. on April 10, 2024). | |||
Form of Restricted Stock Unit Agreement for 2020 Equity Incentive Plan (incorporated by reference to Exhibit 4.5 to Form S-8, File No. 333-238262, filed by Intevac, Inc. on May 14, 2020). | |||
Form of Performance Based Restricted Stock Unit Agreement for 2020 Equity Incentive Plan (incorporated by reference to Exhibit 4.6 to Form S-8, File No. 333-238262, filed by Intevac, Inc. on May 14, 2020). | |||
Form of Outside Director Restricted Stock Unit Agreement for 2020 Equity Incentive Plan (incorporated by reference to Exhibit 4.8 to Form S-8, File No. 333-238262, filed by Intevac, Inc. on May 14, 2020). | |||
Intevac, Inc. 2022 Inducement Equity Incentive Plan, as amended July 1, 2024, (incorporated by reference to Exhibit 10.6 to Quarterly Report on Form 10-Q, File No. 000-26946, filed by Intevac, Inc. on August 6, 2024). | |||
Form of RSU Agreement under the Intevac, Inc. 2022 Inducement Equity Incentive Plan (incorporated by reference to Exhibit 10.3 to Current Report on Form 8-K, File No. 000-26946, filed by Intevac, Inc. on January 20, 2022). | |||
(e)(18) | Intevac, Inc. 401(k) Profit Sharing Plan (incorporated by reference to Registration Statement on Form S-1, File No. 33-97806). (P) | ||
Form of Director and Officer Indemnification Agreement (incorporated by reference to Exhibit 10.9 to Annual Report on Form 10-K, File No. 000-26946, filed by Intevac, Inc. on March 17, 2008). | |||
Intevac, Inc. Executive Incentive Program (incorporated by reference to Exhibit 10.1 to Quarterly Report on Form 10-Q, File No. 000-26946, filed by Intevac, Inc. on May 4, 2023). | |||
Employment Agreement, dated January 18, 2022, by and between Nigel Hunton and Intevac, Inc. (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K, File No. 000-26946, filed by Intevac, Inc. on January 20, 2022). | |||
Amendment to Employment Agreement, dated December 12, 2024, by and between Nigel Hunton and Intevac, Inc. (incorporated by reference to Exhibit 10.19 to Annual Report on Form 10-K, File No. 000-26946, filed by Intevac, Inc. on February 14, 2025). | |||
Form of 2022 PRSU Award Agreement (Company Stock Price Hurdle) under the 2022 Inducement Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K, File No. 000-26946, filed by Intevac, Inc. on May 19, 2022). | |||
Form of 2022 PRSU Award Agreement (Company Stock Price Hurdle) under the 2020 Equity Incentive Plan (incorporated by reference to Exhibit 10.2 to Current Report on Form 8-K, File No. 000-26946, filed by Intevac, Inc. on May 19, 2022). | |||
Form of 2023 PRSU Award Agreement under the 2020 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to Quarterly Report on Form 10-Q, File No. 000-26946, filed by Intevac, Inc. on August 3, 2023). | |||
Form of 2024 PRSU Award Agreement (Grant 1) under the 2020 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to Quarterly Report on Form 10-Q, File No. 000-26946, filed by Intevac, Inc. on August 6, 2024). | |||
Form of 2024 PRSU Award Agreement (Grant 2) under the 2020 Equity Incentive Plan (incorporated by reference to Exhibit 10.2 to Quarterly Report on Form 10-Q, File No. 000-26946, filed by Intevac, Inc. on August 6, 2024). | |||
Exhibit No. | Description | ||
Form of 2024 PRSU Award Agreement (Grant 1) under the 2022 Inducement Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to Quarterly Report on Form 10-Q, File No. 000-26946, filed by Intevac, Inc. on November 12, 2024). | |||
Form of 2024 PRSU Award Agreement (Grant 2) under the 2022 Inducement Equity Incentive Plan (incorporated by reference to Exhibit 10.2 to Quarterly Report on Form 10-Q, File No. 000-26946, filed by Intevac, Inc. on November 12, 2024). | |||
Form of 2025 PRSU Award Agreement (Grant 1) under the 2020 Equity Incentive Plan (incorporated by reference to Exhibit 10.27 to Annual Report on Form 10-K, File No. 000-26946, filed by Intevac, Inc. on February 14, 2025). | |||
Form of 2025 PRSU Award Agreement (Grant 2) under the 2020 Equity Incentive Plan (incorporated by reference to Exhibit 10.28 to Annual Report on Form 10-K, File No. 000-26946, filed by Intevac, Inc. on February 14, 2025). | |||
Form of the CEO 2025 PRSU Award Agreement (Grant 1) under the 2020 Equity Incentive Plan (incorporated by reference to Exhibit 10.29 to Annual Report on Form 10-K, File No. 000-26946, filed by Intevac, Inc. on February 14, 2025). | |||
Form of the CEO 2025 PRSU Award Agreement (Grant 2) under the 2020 Equity Incentive Plan (incorporated by reference to Exhibit 10.30 to Annual Report on Form 10-K, File No. 000-26946, filed by Intevac, Inc. on February 14, 2025). | |||
Form of Outside Director Stock Option Agreement for 2020 Equity Incentive Plan (incorporated by reference to Exhibit 10.3 to Quarterly Report on Form 10-Q, File No. 000-26946, filed by Intevac, Inc. on August 6, 2024). | |||
Amended and Restated Change in Control Agreement with John Dickinson dated December 11, 2024 (incorporated by reference to Exhibit 10.32 to Annual Report on Form 10-K, File No. 000-26946, filed by Intevac, Inc. on February 14, 2025). | |||
Offer Letter, effective as of July 9, 2024, between Intevac and Cameron McAulay (incorporated by reference to Exhibit 10.7 to Quarterly Report on Form 10-Q, File No. 000-26946, filed by Intevac, Inc. on August 6, 2024). | |||
Amended and Restated Change in Control Agreement with Cameron McAulay dated December 11, 2024 (incorporated by reference to Exhibit 10.34 to Annual Report on Form 10-K, File No. 000-26946, filed by Intevac, Inc. on February 14, 2025). | |||
Letter agreement dated as of November 8, 2024, between Intevac, Inc. and Palogic Value Management, L.P. and certain of its affiliates (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K, File No. 000-26946, filed by Intevac, Inc. on November 13, 2024). | |||
† | Certain exhibits and schedules have been omitted pursuant to Instruction 1 to Item 1016 of Regulation M-A. Intevac hereby undertakes to furnish supplemental copies of any of the omitted exhibits and schedules upon request by the SEC. |
(P) | Paper exhibit. |
INTEVAC, INC. | |||||||||
By: | /s/ Nigel Hunton | ||||||||
Name: | Nigel Hunton | ||||||||
Title: | President and Chief Executive Officer | ||||||||

1. | reviewed a draft dated February 10, 2025 of the Agreement and Plan of Merger, by and among the Company, Parent and Purchaser (the “Agreement”); |
2. | reviewed certain publicly available business and financial information relating to the Company that we deemed to be relevant; |
3. | reviewed certain information relating to the historical, current and future operations, financial condition and prospects of the Company made available to us by the Company, including financial projections prepared by the management of the Company relating to the Company for the years ending 2025 through 2027; |
4. | spoken with certain members of the management of the Company and certain of its representatives and advisors regarding the business, operations, financial condition and prospects of the Company, the Transaction and related matters; |
5. | compared the financial and operating performance of the Company with that of other public companies that we deemed to be relevant; |
6. | reviewed the current and historical market prices and trading volume for certain of the Company’s publicly traded securities, and the current and historical market prices and trading volume of the publicly traded securities of certain other companies that we deemed to be relevant; and |
7. | conducted such other financial studies, analyses and inquiries and considered such other information and factors as we deemed appropriate. |
